Neuromodulation Closed-Loop Brain-Computer Interfaces Market

The neuromodulation closed-loop brain-computer interfaces market is segmented by Device modality (Implantable responsive neurostimulation systems, Adaptive deep brain stimulation systems, Endovascular / minimally invasive implantable BCI systems, High-bandwidth cortical interface systems, Research-only closed-loop neural interface platforms), Signal and control architecture (Sensing + adaptive stimulation closed-loop systems, Decoding-only implantable BCI systems, Biomarker-triggered stimulation systems, AI-assisted neural decoding and control systems, Cloud-linked neurodata and software layers), Indication (Drug-resistant epilepsy, Parkinson’s disease and movement disorders, Severe motor impairment / communication restoration, Stroke neurorehabilitation, Refractory depression and psychiatric applications), End user (Tertiary neurology and neurosurgery centers, Academic medical centers, Specialty epilepsy centers, Neurorehabilitation institutes, Translational research hospitals), Commercialization stage (Commercial therapy platforms, Early feasibility systems, Clinical trial platforms, Preclinical development systems, Software / algorithm support revenue), and Region. Forecast for 2026 to 2036.